From Chronic Inflammation to Remodeling: Anthocyanins in the Context of Asthma Management
Open Access
- 15 February 2026
- journal article
- review article
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (2) , 323
Abstract
Asthma is a prevalent chronic disease posing substantial health and economic challenges globally. Its progression involves key hallmarks such as inflammation and airway remodeling, mediated by multiple inflammatory biomarkers and pathways. Despite the availability of potent therapeutic options, many patients continue to suffer from uncontrolled asthma. The plasminogen activator inhibitor-1 (PAI-1) signaling pathway is critical in asthma exacerbation and remodeling, with elevated PAI-1 levels linked to disease progression. Anthocyanins (ACNs), potent antioxidants and anti-inflammatory compounds, have shown promise in asthma management. Epidemiological studies associate higher ACN intake with a lower risk of asthma and improved lung function. Preclinical models further demonstrate ACNs’ effectiveness in reducing asthma-related inflammatory cytokines, chemokines, and signaling pathways. Additionally, a human trial suggests ACNs can improve symptom control and lung function. While no direct evidence links ACNs to PAI-1 reduction in asthma, studies in other chronic conditions show ACNs reduce PAI-1 levels, supporting their potential role in asthma. This suggests a promising avenue for exploring their effects on airway remodeling. The lack of robust human studies remains a gap. Future research should focus on establishing direct evidence of ACNs’ impact on PAI-1 levels and remodeling in asthma, providing novel insights into managing asthma as an adjunct.Keywords
This publication has 161 references indexed in Scilit:
- A biphasic response to blueberry supplementation on depressive symptoms in emerging adults: a double-blind randomized controlled trialEuropean Journal of Nutrition, 2024
- Effects of purified anthocyanins supplementation on serum concentration of inflammatory mediators: A systematic review and dose–response meta‐analysis on randomized clinical trialsPhytotherapy Research, 2024
- Preparation of blueberry anthocyanin liposomes and changes of vesicle properties, physicochemical properties, in vitro release, and antioxidant activity before and after chitosan modificationFood Science & Nutrition, 2021
- Potential of anthocyanin as an anti-inflammatory agent: a human clinical trial on type 2 diabetic, diabetic at-risk and healthy adultsInflammation Research, 2021
- Boysenberry and apple juice concentrate reduced acute lung inflammation and increased M2 macrophage‐associated cytokines in an acute mouse model of allergic airways diseaseFood Science & Nutrition, 2021
- Diagnosis and Management of Asthma in AdultsJAMA, 2017
- Blackcurrant anthocyanins modulate CCL11 secretion and suppress allergic airway inflammationMolecular Nutrition & Food Research, 2017
- Transforming growth factor-β and atherosclerosis: interwoven atherogenic and atheroprotective aspectsCell and tissue research, 2011
- The Protective Effect and Action Mechanism of Vaccinium myrtillus L. on Gastric Ulcer in MicePhytotherapy Research, 2011
- Anthocyanidins inhibit migration of glioblastoma cells: Structure‐activity relationship and involvement of the plasminolytic systemJournal of Cellular Biochemistry, 2006